The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Detection of β-lactamase-mediated resistance
Abstract
β-Lactams are the most widely used antibiotics, and β-lactamases are the greatest source of resistance to them. An understanding of β-lactamase detection and identification is therefore valuable. Colorimetric, acidimetric and iodometric tests of β-lactamase production are good, rapid indicators of penicillin and ampicillin resistance in Haemophilus, Moraxella and Neisseria spp. These methods can also be applied to Gram-negative aerobic bacilli but are less useful, since the usual question is not whether a β-lactamase is produced by these organisms, but which β-lactamase? Accurate identification of the β-lactamases of Enterobacteriaceae demands gene or protein sequencing, but the broad type of enzyme produced by an isolate can often be inferred from antibiotic susceptibility data. Resistance to ceftazidime or cefpodoxime implies extended-spectrum β-lactamase (ESBL) production in Escherichia coli and Klebsiella spp., especially if susceptibility to cefoxitin is retained. ESBL production can be confirmed with double disc tests or with various commercial kits. Derepression of AmpC β-lactamases in Enterobacter spp. and Citrobacter freundii is another important mechanism and can be inferred from cross-resistance to β-lactamase inhibitor combinations and to all cephalosporins except fourth-generation agents. Antagonism between cefoxitin and cefotaxime can be used to infer the presence of inducible AmpC enzymes in these species, indicating the risk of segregation of derepressed mutants, but in general this risk is better predicted from accurate speciation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin Substrate
O'Callaghan, C. H., Morris, A., Kirby, S. M., & Shingler, A. H. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.1.4.283 · Cited by 1,837
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Self-citationJarlier, V., Nicolas, M.-H., Fournier, G., & Philippon, A. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.867 · Cited by 1,559
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Self-citationEnterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 889
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Yong, D., Lee, K., Yum, J. H., Shin, H. B., Rossolini, G. M., & Chong, Y. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3798-3801.2002 · Cited by 538
Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacter spp
Kaye, K. S., Cosgrove, S., Harris, A., Eliopoulos, G. M., & Carmeli, Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2628-2630.2001 · Cited by 181
Extended-spectrum beta-lactamases in Pseudomonas aeruginosa
Nordmann, P., & Guibert, M. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.128 · Cited by 172
Bradford, P. A., Yang, Y., Sahm, D. F., Grope, I., Gardovska, D., & Storch, G. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1980 · Cited by 165
Detection of Extended-Spectrum β-Lactamases in Klebsiellae with the Oxoid Combination Disk Method
Carter, M. W., Oakton, K. J., Warner, M., & Livermore, D. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4228-4232.2000 · Cited by 122
Self-citationM'Zali, F. H., Chanawong, A., Kerr, K. G., Birkenhead, D., & Hawkey, P. M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.6.881 · Cited by 120
Early Dissemination of CTX-M-Derived Enzymes in South America
Radice, M. A., Power, P. P., Conza, J. D., & Gutkind, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.602-604.2002 · Cited by 108
Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone
Bosi, C., Davin‐Regli, A., Bornet, C., Malléa, M., Pagès, J., & Claude Bollet, C. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2165-2169.1999 · Cited by 101
Rice, L. B., Yao, J. D. C., Klimm, K., Eliopoulos, G. M., & Moellering, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1243 · Cited by 86
Brenwald, N. P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg051 · Cited by 64
Instrumentation in antimicrobial susceptibility testing
Felmingham, D., & Brown, D. F. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.81 · Cited by 54
Self-citation
Cited by
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 716
EUCAST expert rules in antimicrobial susceptibility testing
Leclercq, R., Cantón, R., Brown, D. F. J., Giske, C. G., Heisig, P., MacGowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C., Rossolini, G. M., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03703.x · Cited by 683
Self-citationWoodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Self-citationAntimicrobial Resistance in Haemophilus influenzae
Tristram, S., Jacobs, M. R., & Appelbaum, P. C. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-06 · Cited by 464
The emergence of antibiotic resistance by mutation
Woodford, N., & Ellington, M. J. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01492.x · Cited by 417
Metadata
- Authors
- Livermore, D. M., & Brown, D. F. J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07-01
- Volume
- 48
- Issue
- suppl_1
- Pages
- 59-64
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2098021840
- Cited by
- 307
- References
- 21
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.